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Background
Despite antiretroviral therapy, macrophages remain sig-
nificant cellular reservoirs for HIV infection. Two fatal
macrophage-mediated diseases still occur at a much
higher rate in the HIV-infected and HAART-treated
population: (1) AIDS-related lymphoma (ARL), a nonin-
flammatory disease, and (2) HIV-associated dementia
(HAD), an inflammatory disease. The frequency of HIV-
infected macrophages in ARL is 50%. Macrophages are
the primary HIV-infected cells in the brain. The
mechanisms that lead to the development of these dis-
eases are not understood. Because certain subtypes of
HIV are associated with a higher prevalence of HAD, a
viral genetic determinant for HAD development is likely.
On the other hand, ARL development occurs fairly con-
sistently across multiple HIV subtypes and genetic ana-
lysis has clearly differentiated ARL tissue-associated HIV
from non-ARL tissue HIV within individuals. These
facts raise two questions: (1) Are there tumor-specific
genetic differences among HIV proteins that could influ-
ence the macrophage to accelerate ARL development?
(2) How might HAD-associated and ARL-associated
viruses differ at the genetic and structural levels? Our
goal was to analyze HAD and ARL viral sequences and
determine whether a disease association could be identi-
fied within viral proteins.
Methods
The AIDS and Cancer Specimen Resource (ACSR)
archives tissue samples derived from well-documented
cases of both ARL and HAD. Multisite autopsies of 7
patients with ARL, HAD, and other neurological and
systemic disorders were identified at the ACSR. More
than 20 sequences from each of 5 to 7 tissues from each
patient were sequenced. The HIV nef sequence was
used in multiple genetic analyses, including a neural net
signature pattern analysis, a tertiary structural analysis,
and an analysis of the stability of an HIV viral micro-
RNA associated with apoptosis.
Results
Signature pattern analysis clearly separated ARL from
HAD viruses and identified positions that may in con-
cert produce specific pathological outcomes. HIV sub-
type D viruses are known to be associated with a high
rate of HAD. Comparative tertiary structural analysis of
nef showed that HAD viruses were more similar to HIV
subtype D viruses than ARL viruses. ARL viruses were
either missing or possessed a less stable miR-H1 struc-
ture compared to HAD viruses.
Conclusions
Our results show that HIV-associated diseases are likely
related to specific viral genetic signatures and structures.
Discovery of an ARL virus would enable the develop-
ment of diagnostic tools and identify subsets of viruses
to be targeted with drugs or vaccines.
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